HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 257 filers reported holding HAEMONETICS CORP in Q2 2019. The put-call ratio across all filers is 2.19 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $270,196 | -1.2% | 3,266 | +1.9% | 0.00% | 0.0% |
Q1 2024 | $273,461 | -51.2% | 3,204 | -51.1% | 0.00% | -50.0% |
Q4 2023 | $560,689 | -42.2% | 6,557 | -39.4% | 0.00% | -50.0% |
Q3 2023 | $969,435 | +27.1% | 10,822 | +20.8% | 0.00% | +33.3% |
Q2 2023 | $762,599 | +418.8% | 8,957 | +298.1% | 0.00% | +200.0% |
Q2 2022 | $147,000 | -0.7% | 2,250 | -3.6% | 0.00% | 0.0% |
Q1 2022 | $148,000 | +59.1% | 2,335 | +33.4% | 0.00% | 0.0% |
Q4 2021 | $93,000 | -38.8% | 1,750 | -18.8% | 0.00% | 0.0% |
Q3 2021 | $152,000 | +10.9% | 2,155 | +5.1% | 0.00% | 0.0% |
Q2 2021 | $137,000 | -38.6% | 2,050 | +2.0% | 0.00% | -50.0% |
Q1 2021 | $223,000 | +1293.8% | 2,010 | +1388.9% | 0.00% | – |
Q4 2020 | $16,000 | +33.3% | 135 | 0.0% | 0.00% | – |
Q3 2020 | $12,000 | +500.0% | 135 | +440.0% | 0.00% | – |
Q2 2020 | $2,000 | -33.3% | 25 | 0.0% | 0.00% | – |
Q3 2019 | $3,000 | 0.0% | 25 | 0.0% | 0.00% | – |
Q2 2019 | $3,000 | – | 25 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Black Creek Investment Management Inc. | 1,014,941 | $33,077,000 | 3.62% |
Camber Capital Management LP | 1,202,000 | $39,173,000 | 3.07% |
AMERICAN CAPITAL MANAGEMENT INC | 718,380 | $23,412,000 | 2.76% |
Van Berkom & Associates Inc. | 1,258,322 | $41,009,000 | 2.31% |
SNYDER CAPITAL MANAGEMENT L P | 1,222,547 | $39,843,000 | 2.07% |
KESTREL INVESTMENT MANAGEMENT CORP | 441,250 | $14,380,000 | 1.78% |
STONE RUN CAPITAL, LLC | 33,740 | $1,100,000 | 0.80% |
HERMES INVESTMENT MANAGEMENT LTD | 728,123 | $23,730,000 | 0.75% |
ANCHOR CAPITAL ADVISORS LLC | 1,119,060 | $36,470,000 | 0.73% |
Netols Asset Management, Inc. | 137,267 | $4,473,000 | 0.72% |